Streetbeat News

Price Targets

HRT

Needham analyst Kyle Peterson has reiterated a Buy rating on HireRight Holdings (NYSE:HRT) and maintained a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:26 am

RLAY

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Relay Therapeutics (NASDAQ:RLAY) but reduced the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:26 am

PSTX

HC Wainwright & Co. analyst Arthur He has reaffirmed a Buy rating on Poseida Therapeutics (NASDAQ:PSTX) and increased the price target from $15 to $20. This adjustment reflects a positive outlook on the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:23 am

EQR

Mizuho analyst Haendel St. Juste has downgraded Equity Residential (EQR) from Buy to Neutral and reduced the price target from $62 to $58.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:23 am

HUMA

HC Wainwright & Co. analyst Vernon Bernardino has initiated coverage on Humacyte (NASDAQ:HUMA) with a Buy rating and set a price target of $6. This new coverage could influence investor sentiment and potentially impact the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:21 am

AAPL

Wedbush analyst Daniel Ives has raised the price target for Apple Inc. (NASDAQ:AAPL) from $240 to $250 and maintains an Outperform rating. Ives predicts Apple will reach a $4 trillion valuation by the end of 2024, driven by strong iPhone sales and a shift in production from China to India. He anticipates a robust holiday season and a renaissance of growth for the company.

Portfolio Pulse from Shanthi Rexaline

December 11, 2023 | 11:21 am

DPZ

Piper Sandler analyst Brian Mullan has downgraded Domino's Pizza (NYSE:DPZ) from Overweight to Neutral and reduced the price target from $401 to $400.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:20 am

ACLX

Needham analyst Gil Blum has reaffirmed a Buy rating on Arcellx (NASDAQ: ACLX) and increased the price target from $60 to $65.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:18 am

LSTR

JP Morgan analyst Brian Ossenbeck has initiated coverage on Landstar System (NASDAQ:LSTR) with a Neutral rating and set a price target of $186 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 11:16 am

BBY

Jefferies analyst Jonathan Matuszewski has upgraded Best Buy Co (NYSE:BBY) from Hold to Buy and increased the price target from $69 to $89, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 11, 2023 | 10:26 am